Figure 4 — Investigation of Tongxie-Yaofang formula in treating ulcerative colitis based on network pharmacology via regulating MAPK/AKT signaling pathway

Navigate

Research Paper|Volume 16, Issue 2|pp. 1911–1924

Investigation of Tongxie-Yaofang formula in treating ulcerative colitis based on network pharmacology via regulating MAPK/AKT signaling pathway

Back to articleFigure 4(4 of 6)

100%

Figure 4.Molecular docking of active ingredients in TXYF. (A) The molecular docking diagram of naringin and MAPK. (B) The molecular docking diagram of albiflorin and SRC.

Figure 4 — Investigation of Tongxie-Yaofang formula in treating ulcerative colitis based on network pharmacology via regulating MAPK/AKT signaling pathway | Aging